UDSKRIFT 🔗
WEBVTT
00:00:05.679 --> 00:00:08.720
Imagine a dog named Bear.
00:00:09.039 --> 00:00:10.880
And Bear is a Doberman.
00:00:11.199 --> 00:00:14.720
And Bear loves two things in this world.
00:00:15.199 --> 00:00:17.920
Playing hard and dinner time.
00:00:18.719 --> 00:00:20.559
But here's the strange part.
00:00:21.039 --> 00:00:32.399
Every single time someone brings out his food bowl, every time the excitement peaks, Bear's legs will buckle, his head drops.
00:00:32.799 --> 00:00:43.280
For a few seconds, he simply collapses, fully conscious, fully aware, watching his own dinner, but unable to move a muscle.
00:00:44.399 --> 00:00:51.520
This dog, Bear, is one of a colony of narcoleptic Dobermen studied at Stanford.
00:00:51.920 --> 00:00:56.960
They helped crack open one of the great mysteries of modern neuroscience.
00:00:57.439 --> 00:01:06.879
Because what was happening to Bear's brain in that moment of collapsing is happening right now in an exam room across the world.
00:01:07.120 --> 00:01:10.640
These are patients who fall asleep, mid-sentence.
00:01:11.120 --> 00:01:16.879
It's the ones who describe brain fog that no antidepressant seems to touch.
00:01:17.439 --> 00:01:24.959
And the ones who tell you, almost embarrassed, that strong emotion, laughter, surprise makes their knees give out.
00:01:25.680 --> 00:01:30.959
The molecule responsible has one of the more poetic names in pharmacology.
00:01:31.200 --> 00:01:33.599
It's called Orexin.
00:01:34.239 --> 00:01:39.359
And today we're going to spend some time talking about it.
00:01:40.480 --> 00:01:44.719
Well, folks, welcome back to Positive Psychiatry with Rakesh Jan.
00:01:45.040 --> 00:01:47.680
I'm of course Rakesh, your host.
00:01:48.000 --> 00:01:58.799
And if you are a regular listener, you know that the show lives at the intersection of hard neuroscience and the actual patients sitting across from us in clinic.
00:01:59.359 --> 00:02:02.879
Today's topic sits exactly at that intersection.
00:02:03.280 --> 00:02:11.759
And honestly, it's one I've been wanting to tell this story to you for a while, because the timing could not be better.
00:02:12.400 --> 00:02:14.400
We're talking about arexin.
00:02:14.560 --> 00:02:20.479
It used to be called hypocretin, but pretty much we have settled on this name.
00:02:21.759 --> 00:02:23.680
Alright, so here's our roadmap.
00:02:23.840 --> 00:02:31.919
First, I want to tell you the discovery story, and it's really quite a cool story worthy of Hollywood, Bollywood.
00:02:32.159 --> 00:02:37.280
It's a scientific race story, a colony of narcoleptic dogs.
00:02:37.919 --> 00:02:41.439
And there are twists and turns in this story.
00:02:42.400 --> 00:02:47.360
Second, we will build the neurobiology from the ground up.
00:02:48.000 --> 00:02:51.039
Where do these orexin neurons live?
00:02:51.360 --> 00:02:53.599
What do their receptors do?
00:02:53.919 --> 00:03:03.680
And what a beautifully simple model for how our brain decides moment to
Load full transcript
moment whether to be asleep or awake.
00:03:05.039 --> 00:03:07.439
And third, we go clinical.
00:03:07.919 --> 00:03:14.319
Narcolepsy and a genuinely historic FDA approval that happened just a few days ago.
00:03:15.280 --> 00:03:20.719
And fourth, we flip the molecule around and we talk about insomnia too.
00:03:21.039 --> 00:03:26.479
The drug class built to block orxin instead of boost it.
00:03:26.800 --> 00:03:40.800
So either way, clinically, to boost orxin and its functioning, or to inhibit its functioning, can lead inappropriate patients to helping them.
00:03:41.280 --> 00:04:00.879
And finally, of course, the part I and you care most about, we talk about Orexin's emerging role in depression and anxiety and addiction and perhaps even wellness, because this system reaches far beyond sleep medicine and into the core of what we treat every day.
00:04:01.599 --> 00:04:07.919
So this conversation I hope will be scientific, useful, and let's get into it.
00:04:09.199 --> 00:04:11.840
Let's go back to 1998.
00:04:12.319 --> 00:04:15.039
That wasn't that long ago, was it?
00:04:15.199 --> 00:04:17.759
That was just 28 years ago.
00:04:18.000 --> 00:04:34.240
And here's where the story gets interesting, because there are two separate laboratories, not collaborating, not even aware of exactly how close the other was, but they were both closing in on the same discovery from two completely different directions.
00:04:34.720 --> 00:04:48.639
Here in Texas, at the University of Texas Southwestern in Dallas, Takeshi Sakurai and colleagues were doing what's called reverse pharmacology.
00:04:49.040 --> 00:05:00.240
They had a receptor with no known partner, which scientists often call an orphan receptor, sitting on the surface of cells in the hypothalamus.
00:05:00.399 --> 00:05:02.480
They didn't know what turned it on.
00:05:02.800 --> 00:05:06.160
So they went looking for the key that fit this lock.
00:05:06.399 --> 00:05:09.040
What they found was a small peptide.
00:05:09.680 --> 00:05:14.800
And when they injected it into rats, the rats ate a lot.
00:05:15.680 --> 00:05:21.360
So they named it after the Greek word orexis, which means appetite.
00:05:21.519 --> 00:05:27.279
So they named it or almost the exact same time.
00:05:47.519 --> 00:05:53.600
They noticed their peptide had a structure a little like incretin hormones from the gut.
00:05:53.839 --> 00:05:59.279
So they called it hypocretin because hypothalamus plus incretin.
00:05:59.759 --> 00:06:01.439
Now here's the thing.
00:06:02.000 --> 00:06:03.759
Exactly the same molecule.
00:06:04.079 --> 00:06:08.560
Two names published within about a month of each other in 1998.
00:06:09.519 --> 00:06:22.079
And to these, to this day, both names survive in the literature, which is why you'll still see hypocritin 1 on a cerebrospinal fluid lab report, even though most of us today say orxin.
00:06:22.639 --> 00:06:25.839
I think we ought to settle on the word orexin.
00:06:26.079 --> 00:06:27.839
The FDA certainly did.
00:06:28.399 --> 00:06:38.319
Now here's where it gets interesting because appetite was only the first incomplete answer to what this molecule actually does.
00:06:38.879 --> 00:06:45.120
So let's go back to the 1970s, 20 some years before the discovery of Orexin.
00:06:45.439 --> 00:06:48.240
Again, back to Stanford, in Dr.
00:06:48.319 --> 00:06:51.040
William Dement's sleep laboratory.
00:06:51.199 --> 00:06:54.639
And Dement is one of the founding fathers of sleep medicine.
00:06:54.800 --> 00:06:59.199
In fact, I have one of his books right here at home.
00:07:00.319 --> 00:07:02.879
He's one of the founding fathers of sleep medicine.
00:07:03.040 --> 00:07:14.000
He had a colony of dogs, bare the Doberman, I mentioned at the very top of this podcast among them, that had a spontaneous, inherited form of narcolepsy.
00:07:14.240 --> 00:07:23.759
These dogs would be playing or approaching food and then collapse, wide awake, but the muscles just have no more tone.
00:07:24.000 --> 00:07:29.519
That's called cataplexy, and we define it precisely in a moment or two.
00:07:30.160 --> 00:07:32.480
For 20 years, nobody knew why.
00:07:32.720 --> 00:07:46.480
Then in about 1999, a researcher in that same Stanford lineage, Emmanuel Mignot, M-I-G-N-O-T, or sometimes also pronounced Mignot, found it.
00:07:46.800 --> 00:07:53.519
I have had the pleasure of meeting this gentleman, and he's quite a wonderful person and quite a character.
00:07:53.839 --> 00:08:02.160
He identified a mutation in the gene, the dogs and the dogs, and it's called C-A-N-A-R-C1.
00:08:02.560 --> 00:08:09.680
And when they sequenced it, it actually turned out to encode for Orexin type 2 receptor.
00:08:10.399 --> 00:08:12.399
So think about the sequence of events.
00:08:12.560 --> 00:08:16.800
One molecule discovered twice, initially thought to be about appetite.
00:08:17.040 --> 00:08:43.279
Then within about 18 months, a canine sleep disorder traced directly back to the mutated orexin receptor and almost simultaneously, orxin knockout mice, which is a pretty fancy way of saying these mice are bred and engineered with no orxin at all, were shown to have spontaneous behavioral arrest, very similar to human cataplexy.
00:08:43.759 --> 00:08:50.720
So now we have three independent lines of evidence converging on the same conclusion within about two years.
00:08:51.039 --> 00:09:00.000
This molecule wasn't primarily about appetite, it was about the stability of wakefulness itself.
00:09:01.440 --> 00:09:07.679
And then, as the story unfolds, my dear friends, then came the human confirmation.
00:09:07.759 --> 00:09:11.600
And this is the part I find genuinely moving as a clinician.
00:09:11.919 --> 00:09:19.840
In the year 2000, Mignot's group measured orxin in the cerebrospinal fluid of people with narcolepsy.
00:09:20.399 --> 00:09:27.039
In the form that we now call narcolepsy type 1, the orexin was almost completely gone.
00:09:27.360 --> 00:09:30.559
Undetectable, in fact, in most cases.
00:09:41.120 --> 00:09:46.159
It's in fact caused by the loss of neurons that make orexin in the first place.
00:09:46.639 --> 00:09:59.120
Though what we now understand, it's actually an autoimmune process, selectively destroying somewhere between 10 and 70,000 orexin-producing neurons in the hypothalamus.
00:09:59.360 --> 00:10:10.320
We will come back to exactly how we think this happens because there's a fascinating and clinically important detail involving a flu vaccine used in Europe.
00:10:11.360 --> 00:10:12.320
But you know what?
00:10:12.559 --> 00:10:23.200
First, we gotta build the actual neurobiology story because one cannot understand the clinical picture without understanding the wiring.
00:10:24.240 --> 00:10:32.639
So now in the next section, we will talk about neurobiology, focusing on anatomy, receptors, and the flip-flop switch.
00:10:32.960 --> 00:10:35.440
You heard me right, flip-flop switch.
00:10:35.679 --> 00:10:38.080
So let's start with the real estate, okay?
00:10:38.399 --> 00:10:42.639
Orexineurons are not spread diffusely throughout the brain.
00:10:42.799 --> 00:10:47.120
In fact, they live in a remarkably small, specific address.
00:10:47.759 --> 00:10:54.559
The lateral hypothalamus and the periphornical area immediately around it.
00:10:54.799 --> 00:11:01.039
So the lateral hypothalamus and the periphornical area around it are really the homes.
00:11:01.519 --> 00:11:05.600
They are the ground center for erection neurons.
00:11:05.759 --> 00:11:13.360
So in humans, we're talking about a population in the order of just 50 to 80,000 neurons.
00:11:13.519 --> 00:11:17.120
That's really tiny by brain standards.
00:11:17.279 --> 00:11:20.720
Well, remember the brain has several billion neurons.
00:11:20.879 --> 00:11:25.360
50 to 80,000 is not even a rounding error.
00:11:25.840 --> 00:11:28.399
But man, these neurons matter.
00:11:28.720 --> 00:11:32.639
Because what these neurons lack in number, they make up for in reach.
00:11:33.039 --> 00:11:42.720
From that small hypothalamic address, these orexin receptors project almost everywhere that matters for arousal, for wakefulness.
00:11:42.879 --> 00:11:48.960
So it goes to the locus ceruleus, which is the brain's main noroadrenergic engine.
00:11:49.200 --> 00:12:14.399
It also goes to the dorsal raffinucleus, which is a source of serotonergic output, the tuberomamillary nucleus, the brain's histamine center, the ventraltagmental area, which is central to dopaminergic reward circuits, and of course also to the basal forebrain cortex and the cholinergic and gabaergic populations of the brainstem that regulate REM sleep.
00:12:14.639 --> 00:12:17.440
Good lord, good heavens.
00:12:17.759 --> 00:12:30.879
So from one single 50 to 80,000 neuron center in the brain, which is seriously, when the brain looks at 50 to 80,000 and goes, come on now.
00:12:31.200 --> 00:12:47.120
But these are Rexin receptors because of their reach into
norepinephrine, serotonin, dopamine, GABA, and glutamate profoundly control our wakefulness as well as our sleep.
00:12:47.519 --> 00:13:00.240
Now let's get a little bit geeky because structurally, from one gene, and that gene is called preproorexin, so both preproorexin, the body cleaves two active peptides.
00:13:00.559 --> 00:13:02.559
Those are called orexin A.
00:13:02.720 --> 00:13:09.360
It's about 33 amino acids long and orxin B, which is 28 amino acids long.
00:13:09.519 --> 00:13:11.919
Now, orxin A is remarkably stable.
00:13:12.159 --> 00:13:16.639
Orexin B is more like a straightened out cousin of the same molecule.
00:13:16.879 --> 00:13:28.159
Now these two peptides act on two receptors, and here's the detail that actually matters clinically, because it'll explain to us why some drugs are selective and others aren't.
00:13:28.399 --> 00:13:38.080
So orxin receptor type 1, you will see that reference in the literature as OX1R, strongly prefers or.
00:15:37.919 --> 00:15:42.320
If one side is up, the other's down, and vice versa.
00:15:42.559 --> 00:15:44.559
Just visualize that in your brain.
00:15:44.720 --> 00:15:49.039
Two children sitting on a teeter-totter, one is up, one is down.
00:15:49.200 --> 00:15:56.720
On a teeter-tatter, both children cannot be both up at the same time, or both down at the same time.
00:15:56.960 --> 00:15:58.080
You get it, right?
00:15:58.240 --> 00:16:00.639
That's exactly what's happening in our brain.
00:16:00.799 --> 00:16:02.879
It's quite literally a switch, folks.
00:16:03.200 --> 00:16:16.080
And like any other switch built on mutual inhibition, it's designed to snap decisively into one state or the other, rather than hover uncertainly in between.
00:16:16.399 --> 00:16:19.200
Think again about tiratar.
00:16:20.080 --> 00:16:21.600
This design is elegant.
00:16:21.759 --> 00:16:23.440
Nature has done a fabulous job.
00:16:23.600 --> 00:16:25.360
Congratulations, dear nature.
00:16:25.919 --> 00:16:28.000
But it does have a vulnerability.
00:16:28.240 --> 00:16:38.559
A switch with no stabilizing mechanism is prone to flickering, rapid involuntary transitions back and forth, and this is where orexin comes in.
00:16:39.039 --> 00:17:06.640
So rexin neurons don't act as one side of the switch, they act as the hand steadying the switch, reinforcing whatever state the system has committed to, and critically suppressing REM generating circuits during wakefulness so that REM sleep phenomena like muscle atonia, which is like your muscles becoming really flaccid, don't intrude while we are awake.
00:17:06.799 --> 00:17:09.839
Because when I'm awake, I need my muscles to have tone.
00:17:10.160 --> 00:17:17.599
But when I'm in my REM sleep, I want to be really, those muscles are totally flat out, paralyzed.
00:17:18.079 --> 00:17:19.119
So that's all good.
00:17:19.279 --> 00:17:24.240
But if you take the orexin away and the switch still exists, guess what?
00:17:24.319 --> 00:17:26.160
It becomes very unstable.
00:17:26.400 --> 00:17:30.960
Wakefulness collapses abruptly into sleep-like states.
00:17:31.200 --> 00:17:32.319
Think about bear.
00:17:32.799 --> 00:17:35.279
Think about our patients with narcolepsy.
00:17:35.599 --> 00:17:40.559
REM-associated muscle atonia leaks into full consciousness.
00:17:40.880 --> 00:17:44.480
This instability is what we call narcolepsy.
00:17:44.799 --> 00:17:48.640
We just are now understanding it at a circuit level.
00:17:49.599 --> 00:17:51.359
I want you to hold on to that image.
00:17:51.599 --> 00:18:01.599
Orexin as the stabilizing hand on the switch, because everything clinical we discussed for the rest of this episode is really just different ways of asking.
00:18:01.920 --> 00:18:04.880
What happens when that hand gets weaker?
00:18:05.119 --> 00:18:10.480
And what happens when we deliberately make it stronger or weaker with the drug?
00:18:12.880 --> 00:18:16.319
Okay, let's shift gears a little bit.
00:18:16.480 --> 00:18:22.319
Let's put this model to clinical use, starting with narcolepsy type 1.
00:18:22.799 --> 00:18:27.759
Because a drug just got approved that just made history.
00:18:28.480 --> 00:18:33.759
Let's talk a little bit about narcolepsy type 1, or also known as NT1.
00:18:34.319 --> 00:18:40.319
NT1 is defined by two things: excessive daytime sleepiness and cataplexy.
00:18:40.559 --> 00:18:41.440
You got it?
00:18:41.759 --> 00:18:45.119
Excessive daytime sleepiness and cataplexy.
00:18:45.359 --> 00:18:48.319
Why don't we define cataplexy precisely?
00:18:48.559 --> 00:18:53.599
Because it's frequently misdiagnosed as a seizure or a psychogenic event.
00:19:05.599 --> 00:19:18.400
And what it is is, from a mechanistic perspective, an intrusion of REM sleep muscle atonia, atonia, which pretty much means no tone, into wakefulness states.
00:19:18.640 --> 00:19:25.279
Remember Bert the Doberman collapsing at the site of his food bowl that he had been looking forward to all day?
00:19:25.680 --> 00:19:29.839
Same phenomena translated into a human nervous system.
00:19:30.480 --> 00:19:52.319
Patients also frequently describe hypnagogic hallucinations, sleep paralysis, and fragmented nighttime sleep, which is a detail I want to underline for a psychiatric audience like you and I, because narcolepsy is not simply, quote, too much daytime sleep, end quote.
00:19:52.960 --> 00:19:55.440
The nighttime is shot too, folks.
00:19:55.680 --> 00:19:58.000
Nighttime sleep is very disrupted.
00:19:58.079 --> 00:20:02.079
The whole 24-hour day architecture is destabilized.
00:20:02.880 --> 00:20:03.680
Not good.
00:20:04.559 --> 00:20:14.880
The underlying pathology, as we discussed, is in fact an autoimmune destruction of the orxin-producing neurons, typically more than 90% loss.
00:20:15.599 --> 00:20:18.799
And there's a striking piece of history here.
00:20:19.039 --> 00:20:34.000
A cluster of narcolepsy cases in part of Europe followed the H1N1 pandemic of 2009, because what that
did is linked to a particular vaccination formulation used there.
00:20:34.400 --> 00:20:57.119
The leading hypothesis is that molecular mimicry and immune response is genetically, in people who are genetically susceptible, it cross-reacted with orexin neurons themselves, and it remains one of the more compelling natural experiments linking infection, immunity, and a specific neuronal population.
00:20:57.920 --> 00:21:03.279
Now for decades, everything we had to treat narcolepsy type 1 was symptomatic.
00:21:03.440 --> 00:21:12.960
We used stimulants, we used wake-promoting agents, modafinil, armodafinyl, sodium oxabate, all good drugs.
00:21:13.920 --> 00:21:16.319
But they were only treating symptoms.
00:21:16.960 --> 00:21:23.599
Then we used petalocent, which works one step downstream of forexin on histamine H3 receptors.
00:21:23.920 --> 00:21:29.440
But all of these are treating the symptoms of this condition.
00:21:29.599 --> 00:21:31.599
They're not actually treating the condition.
00:21:31.839 --> 00:21:35.200
None of them replace what's actually missing.
00:21:36.400 --> 00:21:45.839
All this changed on August 5th, 2026, because the FDA approved a drug called oviporextin.
00:21:46.960 --> 00:21:50.640
O V-E-P-O-R-E-X-T-O-N.
00:21:50.960 --> 00:21:54.960
Oviporextin and its brand name is Orzifol.
00:22:00.240 --> 00:22:01.119
In adults.
00:22:01.359 --> 00:22:08.640
Now, this is the first orxin receptor agonist ever approved, and it is an oral twice-daily medication.
00:22:08.880 --> 00:22:25.200
It is selective for OX2R, so it's selective for Orexin 2 receptor, and it's designed to do the one thing no prior narcolepsy treatment could do, that being directly restore orxin receptor signaling.
00:22:25.440 --> 00:22:30.799
Think about what this means for the flip-flop switch model we just built.
00:22:30.960 --> 00:22:42.799
Every prior narcolepsy treatment worked around the missing hand on the switch, which is propping up wakefulness with stimulants or dampening down fragmented sleep with sodium oxabate.
00:22:43.359 --> 00:22:52.000
Now, this particular molecule, this particular new approval by the FDA, is actually designed to put a hand back on the switch.
00:22:52.720 --> 00:22:55.519
So, what was the data that backed this up?
00:22:55.759 --> 00:23:14.640
Well, it rested on two 12-week placebo control trials in adults with narcolepsy type 1, showing improvement across both daytime wakefulness and cataplexy, meaning, notably, benefit across the full symptom complex of the disease, not just one piece of it.
00:23:15.200 --> 00:23:34.480
The most common side effect that I saw in these papers, insomnia, urinary urgency, hypersalivation, which, if you think about the OX2R's broad distribution beyond just the arousal circuit, makes physiological sense.
00:23:35.200 --> 00:23:47.839
One more detail worth knowing because patients will ask, we will not yet have commercial availability till the DEA scheduling determination happens, which takes
about 90 days or so.
00:23:48.480 --> 00:23:59.839
Okay, now that we have talked a little bit about Orexin receptor to agonist, I think we need to talk about the other side of the story.
00:24:00.000 --> 00:24:02.559
Let's flip the whole story around.
00:24:02.799 --> 00:24:12.559
Because if losing orexin signaling causes pathological sleepiness, what happens if one deliberately, pharmacologically, turns it down?
00:24:12.960 --> 00:24:22.400
And someone who has plenty of orxin, perhaps even too much, but whose arousal system simply won't power down at night.
00:24:22.880 --> 00:24:34.640
See, that's the logic behind an entirely new class of medications that we have been using for a while called the dual orexin receptor antagonists, or DORA.
00:24:35.759 --> 00:24:37.839
So they are currently on the market.
00:24:38.000 --> 00:24:39.920
We call them Suvorexin.
00:24:40.160 --> 00:24:55.200
Brand name is Belsomra, that was approved in 2014, Lemborexin, DeVigo, that came in 2019, and then came Doritorexin, Quivavig, that arrived in 2022.
00:24:56.160 --> 00:25:08.319
All three block both the orxin 1 and orxin 2 receptors, reducing that wake-promoting signal at night, so the flip-flop switch can settle into sleep more readily.
00:25:08.480 --> 00:25:20.480
Rather than, as sedative hypnotic classes do, like you know, benzos and Z drugs, globally suppressing central nervous system activity through GABA apotentiation.
00:25:21.759 --> 00:25:32.400
Now, this mechanistic distinction is clinically meaningful because DORAs work by removing a wake-promoting signal rather than broadly sedating the brain.
00:25:32.559 --> 00:25:42.319
And they're generally shown to have a more favorable profile on the next day residual effects, and the abuse liability, while not zero, appears to be diminished.
00:25:42.799 --> 00:25:45.680
So, yes, that's something that we need to know.
00:25:46.319 --> 00:25:50.480
Folks have been watching even further refinement on this.
00:25:50.720 --> 00:25:54.240
So DORAS, of course, block both receptors, right?
00:25:54.480 --> 00:25:56.319
Orexin 1 and 2.
00:25:56.720 --> 00:26:13.680
But Celterexant, which is a blocker of just orexin 2 receptors, just orxin 2, is currently being studied to be used in patients with major depression.
00:26:14.160 --> 00:26:15.680
In major depression.
00:26:15.839 --> 00:26:21.119
And we will of course talk much more about that when the time is right.
00:26:21.599 --> 00:26:29.279
So for the time being, just be aware that DORAS, the three that I just mentioned to you, have been available actually for some years now.
00:26:30.079 --> 00:26:37.839
It's also really important to remember that further refinement is occurring in a class called SORAS, SORA.
00:26:38.160 --> 00:26:39.599
What does that stand for?
00:26:39.920 --> 00:26:43.839
Selective orexin receptor antagonist.
00:26:44.000 --> 00:27:10.000
And Celtorxin is one molecule that I would urge you to keep your eyes on, because in patients with mood
difficulties, to be able to block the orexin II receptor may in fact come with benefits not just in sleep, but perhaps even in the neuroimmune system and perhaps even in the HPAxis system.
00:27:10.160 --> 00:27:21.359
Because, as we well know, patients with depression who have untreated sleep difficulties fundamentally are impaired at the brain-body level.
00:27:22.559 --> 00:27:24.319
Now let's do this, folks.
00:27:24.480 --> 00:27:36.000
Let's talk about what matters to all of us in psychiatry, MDs, DOs, NPs, PAs, RNs, social workers, therapists, you name it.
00:27:36.480 --> 00:27:37.759
Let's talk about that.
00:27:37.920 --> 00:27:42.720
Let's remember orexone neurons don't just project to the arousal centers.
00:27:42.880 --> 00:27:50.720
They project heavily into the ventral tegmental area, VTA, the core reward circuitry.
00:27:50.880 --> 00:27:58.480
And their firing is strongly modulated by stress and emotional resilience and reward-predicting cues.
00:27:58.880 --> 00:28:19.200
Now, in animal models, orxin neuron activity rises with stressors and drug-associated cues, and blocking orxin signaling has been shown to blunt drug seeking and reinstatement of behavior that's actually beneficial across multiple substances of abuse.
00:28:19.920 --> 00:28:28.880
So this gives rise to a real ongoing investigation of orexin antagonism as a potential tool for addiction psychiatry.
00:28:29.119 --> 00:28:42.000
No, we don't yet have an approved indication, but this is a genuinely active area of research linked to arousal circuitry directly helping patients who are challenged by cravings and relapse.
00:28:42.720 --> 00:28:43.680
Now let's do this.
00:28:43.759 --> 00:28:47.440
Let's particularly consider depression, major depression.
00:28:47.920 --> 00:28:53.440
And of course, we know there's prominent insomnia and hyperarousal, both.
00:28:53.680 --> 00:28:58.799
The insomnia is in sleep, but the hyperarousal isn't everything in their body.
00:28:59.119 --> 00:29:14.079
There's a compound that we just talked about, Celtrorexant, which is the OX2R orexin 2 receptor antagonist, and is currently in phase 3 development as an adjunctive treatment for major depressive disorder.
00:29:14.400 --> 00:29:23.599
I want to flag this so that we can over time keep our eyes on it because mechanistically the hypothesis is elegant as all get out.
00:29:24.000 --> 00:29:33.279
If there is nighttime hyper-arousal, partly driven by excess oring, well, let's then block the orexin.
00:29:33.359 --> 00:29:38.799
But careful, blocking the orexin 1 receptor, not so helpful.
00:29:38.960 --> 00:29:42.640
In fact, it can rebound and create more troubles for the patient.
00:29:42.960 --> 00:29:45.519
Well, what's the thoughtful clinician to do?
00:29:45.759 --> 00:29:55.759
Well, we should be thinking about blocking the appropriate receptor in this situation, which is not orxin one and two, it's just orxin two.
00:29:56.319 --> 00:30:01.839
I think this should establish for us that we should think about orxin more broadly.
00:30:01.920 --> 00:30:05.680
It's not simply a sleep molecule or a wakefulness molecule.
00:30:05.759 --> 00:30:06.880
It is all that.
00:30:07.359 --> 00:30:15.839
But it really is a salience stabilizing system, and that the sleep wake regulation is simply the most visible expression of it.
00:30:16.079 --> 00:30:21.680
So, yes, these molecules, if we use it, use them correctly.
00:30:21.839 --> 00:30:26.720
So, for example, blocking orxin receptors does help with sleep.
00:30:26.799 --> 00:30:30.079
The data is really, we can't even argue with that.
00:30:30.160 --> 00:30:31.200
That's really very good.
00:30:31.359 --> 00:30:33.759
We have three approved FDA treatments.
00:30:34.000 --> 00:30:38.799
We also have a treatment that's coming online, one hopes.
00:30:39.039 --> 00:30:44.319
That is specifically for one of the two receptors in the orexin family and Celtorxant.
00:30:44.799 --> 00:31:02.319
But we need to celebrate the fact that we now have an orexin agonist, the opposite of an antagonist, in order to help people in a manner that we're not simply treating the symptoms of the disorder, but in fact treating the entirety of the disorder.
00:31:02.880 --> 00:31:07.039
This brings to mind something that is so very interesting.
00:31:07.279 --> 00:31:12.720
So we've spent decades organizing our field around different neurotransmitter systems, haven't we?
00:31:12.960 --> 00:31:18.480
Serotonin, dopamine, norepinephrine, glutamate, GABA, acetylcholine.
00:31:18.960 --> 00:31:24.319
We neatly put them in different buckets, but orexin doesn't fit neatly into that lineup.
00:31:25.039 --> 00:31:29.839
Because it isn't really a mood molecule or a sleep molecule in isolation.
00:31:29.920 --> 00:31:32.480
It's more a coordinating signal molecule.
00:31:32.640 --> 00:31:37.759
It sits upstream to these multiple neurotransmitter systems.
00:31:38.079 --> 00:31:45.119
It tunes arousal, tunes salience, stabilizes the whole system across different states.
00:31:45.440 --> 00:32:02.960
And that's precisely why a single hypothalamic peptide, discovered by two labs chasing appetite and gene expression, completely reshaped our understanding of narcolepsy, insomnia, and possibly depression and anxiety and addiction.
00:32:03.200 --> 00:32:13.440
Now you see, don't you, why I so badly wanted to talk to you about all the developments in the Rexin system.
00:32:14.559 --> 00:32:17.119
Now let's bring all this back to the clinic.
00:32:17.359 --> 00:32:19.599
So I have four takeaways.
00:32:20.079 --> 00:32:21.279
Takeaway one.
00:32:21.680 --> 00:32:34.960
If a patient describes to us sudden brief muscle weakness that are often triggered by strong emotions, particularly laughter, alongside excessive daytime sleepiness, think narcolepsy type one.
00:32:36.160 --> 00:32:44.559
Think about that, because in the vast majority of these patients who do come into the medical system, they're actually ignored.
00:32:44.799 --> 00:32:51.119
They're often called malingering or thought to have seizures or pseudo-seizures or a conversion disorder.
00:32:52.240 --> 00:33:08.319
Consider having a high degree of suspicion, refer to a sleep medicine specialist if you're not one, but polysomnography for multiple sleep latency testing, and if indicated for CSF hypocritin measurement.
00:33:08.559 --> 00:33:10.000
That's their specialty.
00:33:10.079 --> 00:33:11.039
They can take care of it.
00:33:11.200 --> 00:33:19.359
But none of this starts unless I alert the patient and the referral source that hey, we need some help.
00:33:20.240 --> 00:33:24.240
Takeaway number two, know the new landscape.
00:33:24.319 --> 00:33:26.079
Things have really changed.
00:33:26.319 --> 00:33:39.759
As of this month, narcolepsy type 1 has for the very first time an FD-approved treatment, oviporexin, or ze full, is designed to restore Orexin signaling rather than simply manage symptoms.
00:33:40.400 --> 00:33:50.559
We're awaiting DEA scheduling, but this is a conversation we've been wanting to have with narcolepsy patients forever, and we're almost there.
00:33:51.119 --> 00:33:58.880
Number three, when we're choosing among the Dora class of medications for insomnia, remember the mechanism we're leveraging.
00:33:59.119 --> 00:34:05.920
We're quieting the wake-promoting side of the flip-flop switch, not simply sedating the brain broadly.
00:34:06.240 --> 00:34:17.360
That distinction is worth explaining to patients directly, because it often reduces fear of dependency and unrealistic expectations about how the medication should feel.
00:34:18.079 --> 00:34:33.760
Make sure you're also keeping your eyes on the Sora class, the selective Orexin receptor antagonist, Celtorxin being the one member of this class that is most further along.
00:34:34.159 --> 00:34:37.039
And finally, I want to leave you with this.
00:34:37.280 --> 00:34:50.960
Watch for continuing conversation on this because for all the right reasons, psychiatry is now firmly interested in a third of human life, which is sleep.
00:34:51.199 --> 00:34:57.440
But psychiatry has always been interested in the two-thirds of human life, which is wakefulness.
00:34:57.599 --> 00:35:03.039
And Orexin is that one thread that binds both of these together.
00:35:03.280 --> 00:35:03.599
Right?
00:35:03.760 --> 00:35:10.320
Orexin in many ways is indispensable to our thinking as mental health professionals.
00:35:11.519 --> 00:35:17.519
So as we close, let's go back to Bayer, the Doberman who started our conversation.
00:35:18.400 --> 00:35:19.440
Remember Baer?
00:35:19.599 --> 00:35:22.239
He would collapse at the site of his dinner bowl.
00:35:22.480 --> 00:35:30.000
Well, it took 20 years and two competing labs and a colony of narcolepsy dogs and researchers.
00:35:30.480 --> 00:35:34.480
All of that, it took all that time, but look where we are here.
00:35:34.960 --> 00:35:40.159
The story of Orexin is now really mature.
00:35:40.639 --> 00:35:45.920
So a molecule discovered almost accidentally while looking for something about appetite.
00:35:46.000 --> 00:35:56.800
That turns out to be one of the brain's master switches for staying awake, staying asleep, staying calm, avoiding drugs, and possibly even wellness.
00:35:57.440 --> 00:36:07.679
Yes, this is why this conversation on positive psychiatry mandates that we talk about Rexin.
00:36:09.119 --> 00:36:18.800
Folks, this is Rakesh Jan, and I really thank you for spending so much time with me to talk about this remarkable molecule.
00:36:19.199 --> 00:36:31.199
Please stay curious, continue taking care of yourself and your patients, but most of all, I wish you and your patients great well being and wellness.
00:36:31.519 --> 00:36:32.880
Goodbye for now.